Edinburgh, United Kingdom
Kynos Therapeutics is a clinical-stage company, developing an innovative portfolio of first-in-class medicines where there is an unmet medical need for new therapies.
Our medicines block the action of KMO - a key enzyme at the interface of inflammation, immunity and metabolism.
No key contacts have been added to this profile yet.
No reviews have been added to this profile yet.
This is the company profile page for Kynos Therapeutics on the Pharmaceutical Services Directory. Companies listed on the directory can update their business information free of charge. If this is your company and you'd like to claim this profile, please Contact Us.
